TrialJournal for immunotherapy of cancer2020

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients.

Orit Itzhaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.